<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xml:lang="en" article-type="rapid-communication" dtd-version="2.3">
  <front>
    <journal-meta>
      <journal-id journal-id-type="publisher-id">molbank</journal-id>
      <journal-title>Molbank</journal-title>
      <abbrev-journal-title abbrev-type="publisher">Molbank</abbrev-journal-title>
      <abbrev-journal-title abbrev-type="pubmed">Molbank</abbrev-journal-title>
      <issn pub-type="epub">1422-8599</issn>
      <publisher>
        <publisher-name>MDPI</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="doi">10.3390/M733</article-id>
      <article-id pub-id-type="publisher-id">molbank-2011-M733</article-id>
      <article-categories>
        <subj-group>
          <subject>Short Note</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>5-[(5-Chloro-3-methyl-1-phenyl-1<italic>H</italic>-pyrazol-4-yl)methylene]-2-(4-nitrobenzoyl)-3-phenyl-2,5-dihydro-1,2,4-triazin-6(1<italic>H</italic>)-one</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Kaushik</surname>
            <given-names>Darpan</given-names>
          </name>
          <xref rid="c1-molbank-2011-M733" ref-type="corresp">*</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Verma</surname>
            <given-names>Tarawanti</given-names>
          </name>
        </contrib>
      </contrib-group>
      <aff id="af1-molbank-2011-M733">Department of Pharmaceutical Chemistry, RITS, 4th Mile Stone, Hisar Road, Sirsa-125055, India</aff>
      <author-notes>
        <corresp id="c1-molbank-2011-M733"><label>*</label> Author to whom correspondence should be addressed; E-Mail: <email>darpkaush@yahoomail.com</email>.</corresp>
      </author-notes>
      <pub-date pub-type="epub">
        <day>11</day>
        <month>08</month>
        <year>2011</year>
      </pub-date>
      <pub-date pub-type="collection">
        <month>09</month>
        <year>2011</year>
      </pub-date>
      <volume>2011</volume>
      <issue>3</issue>
      <elocation-id>M733</elocation-id>
      <history>
        <date date-type="received">
          <day>12</day>
          <month>05</month>
          <year>2011</year>
        </date>
        <date date-type="accepted">
          <day>05</day>
          <month>08</month>
          <year>2011</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; 2011 by the authors; licensee MDPI, Basel, Switzerland.</copyright-statement>
        <copyright-year>2011</copyright-year>
        <license>
          <p>This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/3.0/).</p>
        </license>
      </permissions>
      <abstract>
        <p>A novel 1,2,4-triazin-6-one derivative (<bold>2</bold>) was synthesized by the reaction of the oxazolone derivative <bold>1</bold> with 4-nitrobenzoic acid hydrazide in the presence of sodium acetate and glacial acetic acid. The title compound <bold>2</bold> was characterized on basis of IR, <sup>1</sup>H-NMR, <sup>13</sup>C-NMR and mass spectral data.</p>
      </abstract>
      <kwd-group>
        <kwd>1,2,4-triazin-6-one</kwd>
        <kwd>2-phenyloxazol-5(4<italic>H</italic>)-one</kwd>
        <kwd>4-nitrobenzoic acid hydrazide</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec id="sec1-molbank-2011-M733" sec-type="intro">
      <title>1. Introduction</title>
      <p>1,2,4-Triazine represents a class of heterocyclic compounds possessing significant biological activities which makes them targets for research in the field of medicine and agriculture [<xref ref-type="bibr" rid="B1-molbank-2011-M733">1</xref>,<xref ref-type="bibr" rid="B2-molbank-2011-M733">2</xref>,<xref ref-type="bibr" rid="B3-molbank-2011-M733">3</xref>]. 1,2,4-Triazines have gained considerable pharmacological interest due to their anticonvulsant [<xref ref-type="bibr" rid="B4-molbank-2011-M733">4</xref>,<xref ref-type="bibr" rid="B5-molbank-2011-M733">5</xref>], anticancer [<xref ref-type="bibr" rid="B6-molbank-2011-M733">6</xref>,<xref ref-type="bibr" rid="B7-molbank-2011-M733">7</xref>,<xref ref-type="bibr" rid="B8-molbank-2011-M733">8</xref>,<xref ref-type="bibr" rid="B9-molbank-2011-M733">9</xref>], antiprotozoal [<xref ref-type="bibr" rid="B10-molbank-2011-M733">10</xref>], anti-viral [<xref ref-type="bibr" rid="B11-molbank-2011-M733">11</xref>], anti-malarial [<xref ref-type="bibr" rid="B12-molbank-2011-M733">12</xref>], antibacterial [<xref ref-type="bibr" rid="B13-molbank-2011-M733">13</xref>,<xref ref-type="bibr" rid="B14-molbank-2011-M733">14</xref>,<xref ref-type="bibr" rid="B15-molbank-2011-M733">15</xref>] and antifungal effects [<xref ref-type="bibr" rid="B16-molbank-2011-M733">16</xref>,<xref ref-type="bibr" rid="B17-molbank-2011-M733">17</xref>,<xref ref-type="bibr" rid="B18-molbank-2011-M733">18</xref>]. In the field of agriculture, they showed effects such as insecticides, herbicides, plant growth regulators and they are deployed for enhancing crop yield [<xref ref-type="bibr" rid="B19-molbank-2011-M733">19</xref>,<xref ref-type="bibr" rid="B20-molbank-2011-M733">20</xref>,<xref ref-type="bibr" rid="B21-molbank-2011-M733">21</xref>].</p>
    </sec>
    <sec id="sec2-molbank-2011-M733" sec-type="results">
      <title>2. Results and Discussion</title>
      <p>The title compound <bold>2</bold> was synthesized by refluxing 4-[(5-chloro-3-methyl-1-phenyl-1<italic>H</italic>-pyrazol-4-yl)methylene]-2-phenyloxazol-5(4<italic>H</italic>)-one <bold>1</bold> (see <xref ref-type="app" rid="app1-molbank-2011-M733">supplementary material</xref>) with 4-nitrobenzoic acid hydrazide in glacial acetic acid in the presence of sodium acetate, as presented in <xref ref-type="scheme" rid="molbank-2011-M733-sch001">Scheme 1</xref>. The utilized azlactone was synthesized by the Erlenmeyer-Plochl method as discussed earlier [<xref ref-type="bibr" rid="B22-molbank-2011-M733">22</xref>]. The acid hydrazide was prepared from the acid <italic>via</italic> esterification followed by hydrazinolysis with hydrazine hydrate. In the present reaction, the acid hydrazide acts as a nucleophile which attacks the carbonyl group of the oxazolone ring, followed by ring cleavage with concomitant cyclization to form the triazinone derivative <bold>2</bold> [<xref ref-type="bibr" rid="B5-molbank-2011-M733">5</xref>].</p>
    </sec>
    <sec id="sec3-molbank-2011-M733" sec-type="methods">
      <title>3. Experimental </title>
      <p>The melting point was determined in an open-end capillary tube on a digital melting point apparatus and is uncorrected. Infrared (IR) and proton nuclear magnetic resonance (<sup>1</sup>H-NMR) spectra were recorded on a Nicolet 380 FT-IR (KBr) and a Bruker DRX-300 instrument, respectively. Chemical shifts are expressed in ppm relative to TMS as an internal standard. The elemental analysis was performed on a Vario EL III CHN analyzer using sulphanilic acid as a standard. The ESI-MS spectrum was recorded on a Waters Micromass Q-TOF Micro. The homogeneity of the compounds was monitored by ascending thin-layer chromatography (TLC), visualized by iodine vapour.</p>
      <sec>
        <title>Synthesis of 5-[(5-chloro-3-methyl-1-phenyl-1H-pyrazol-4-yl)methylene]-2-(4-nitrobenzoyl)-3-phenyl-1, 2-dihydro-1, 2, 4-triazin-6(5H)-one (<bold>2</bold>)</title>
        <p>An equimolar quantity (<italic>i.e.</italic>, 0.01 mol) of compound <bold>1</bold> and of 4-nitrobenzoic acid hydrazide was refluxed along with sodium acetate (0.2 g) in glacial acetic acid (10 mL) for 6 h. The reaction mixture was then poured into crushed ice and stirred vigorously. The solid so obtained was filtered, washed with water, dried and recrystallised from ethanol.</p>
        <p>Yield: 77%; m.p.: 242&#x2013;244 &#xB0;C; R<sub>f</sub>: 0.75; mobile phase:toluene: ethyl acetate: formic acid (5:4:1); yellow crystalline solid.</p>
        <p>IR (KBr) cm<sup>&#x2212;1</sup>: 3273 (N-H), 3052 (aromatic C-H), 2933 (aliphatic C-H), 1719 (CONH), 1665 (C=O), 1609 (C=N, imine), 1576 (C=C), 697 (C-Cl).</p>
        <p><sup>1</sup>H-NMR (300 MHz, CDCl<sub>3</sub>): &#x3B4; (ppm) 10.58 (s, 1H, CON<italic>H</italic>, <italic>D<sub>2</sub>O</italic> exchangeable), 8.17&#x2013;8.15 (d, 2H, <italic>J</italic> = 8.7 Hz, Ar-<italic>H</italic>), 7.99&#x2013;7.92 (m, 4H, Ar-<italic>H</italic>), 7.60&#x2013;7.44 (m, 8H, Ar-<italic>H</italic>), 7.37 (s, 1H, C<italic>H</italic>=C), 2.82 (s, 3H, C<italic>H</italic><sub>3</sub>).</p>
        <p><sup>13</sup>C-NMR (75 MHz, CDCl<sub>3</sub>): &#x3B4; 170.3 (<italic>C</italic>=O, benzoyl), 164.3 (<italic>C<sub>6</sub></italic>), 157.1 (<italic>C<sub>3</sub></italic>), 151.5 (<italic>C</italic>-NO<sub>2</sub>), 150.2 (<italic>C</italic>-CH<sub>3</sub>) 133.8, 132.1, 131.6, 129.2, 129.0, 128.9, 128.1, 127.5, 125.0, 123.8, 122.7, 114.1, 16.6 (C-<italic>C</italic>H<sub>3</sub>).</p>
        <p>Anal. Calcd. for C<sub>27</sub>H<sub>19</sub>ClN<sub>6</sub>O<sub>4</sub>: C, 61.54; H, 3.63; N, 15.94%; Found: C, 61.23; H, 3.89; N, 15.53%.</p>
        <p>ESI-MS: <italic>m/z</italic> = 526.7 (M<sup>+</sup>), 528.7(M<sup>+</sup>+2).</p>
      </sec>
    </sec>
  </body>
  <back>
    <app-group>
    <app id="app1-molbank-2011-M733">
      <title>Supplementary Materials</title>
	  <supplementary-material id="molbank-2011-M733-s001" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="molbank-2011-M733-s001-mod.mol">
	  <label>Supplementary File 1</label>
	  </supplementary-material>
	  <supplementary-material id="molbank-2011-M733-s002" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="molbank-2011-M733-s001.mol">
	  <label>Supplementary File 2</label>
	  </supplementary-material>
	</app>
    </app-group>
	<ack>
      <title>Acknowledgement</title>
      <p>Authors are highly thankful to Rajendra Institute of Technology and Sciences, Sirsa for providing the necessary facilities for carrying out the research work.</p>
    </ack>
    <ref-list>
      <title>References and Notes</title>
      <ref id="B1-molbank-2011-M733">
        <label>1.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Boger</surname>
              <given-names>D.L.</given-names>
            </name>
          </person-group>
          <article-title>Diels-Alder cycloaddition reactions of heterocyclic azadienes: Scope and applications</article-title>
          <source>Chem. Rev.</source>
          <year>1986</year>
          <volume>86</volume>
          <fpage>781</fpage>
          <lpage>793</lpage>
          <pub-id pub-id-type="doi">10.1021/cr00075a004</pub-id>
        </citation>
      </ref>
      <ref id="B2-molbank-2011-M733">
        <label>2.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Boger</surname>
              <given-names>D.L.</given-names>
            </name>
          </person-group>
          <article-title>Diels-Alder reactions of azadienes</article-title>
          <source>Tetrahedron</source>
          <year>1983</year>
          <volume>39</volume>
          <fpage>2869</fpage>
          <lpage>2939</lpage>
          <pub-id pub-id-type="doi">10.1016/S0040-4020(01)92154-4</pub-id>
        </citation>
      </ref>
      <ref id="B3-molbank-2011-M733">
        <label>3.</label>
        <citation citation-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Neunhoeffer</surname>
              <given-names>H.</given-names>
            </name>
          </person-group>
          <source>Comprehensive Heterocyclic Chemistry</source>
          <person-group person-group-type="editor">
            <name>
              <surname>Katritzky</surname>
              <given-names>A.R.</given-names>
            </name>
            <name>
              <surname>Rees</surname>
              <given-names>C.W.</given-names>
            </name>
          </person-group>
          <publisher-name>Pergamon Press</publisher-name>
          <publisher-loc>Oxford, UK</publisher-loc>
          <year>1984</year>
          <fpage>385</fpage>
        </citation>
      </ref>
      <ref id="B4-molbank-2011-M733">
        <label>4.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yuen</surname>
              <given-names>A.W.</given-names>
            </name>
          </person-group>
          <article-title>Lamotrigine: A review of antiepileptic efficacy</article-title>
          <source>Epilepsia</source>
          <year>1994</year>
          <volume>35</volume>
          <fpage>S33</fpage>
          <lpage>S36</lpage>
          <pub-id pub-id-type="doi">10.1111/j.1528-1157.1994.tb05964.x</pub-id>
        </citation>
      </ref>
      <ref id="B5-molbank-2011-M733">
        <label>5.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kaushik</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Khan</surname>
              <given-names>S.A.</given-names>
            </name>
            <name>
              <surname>Chawla</surname>
              <given-names>G.</given-names>
            </name>
          </person-group>
          <article-title>Design &amp; synthesis of 2-(substituted aryloxy)-5-(substituted benzylidene)-3-phenyl-2, 5-dihydro-1<italic>H</italic>-[1, 2, 4] triazin-6-one as potential anticonvulsant agents</article-title>
          <source>Eur. J. Med. Chem.</source>
          <year>2010</year>
          <volume>45</volume>
          <fpage>3960</fpage>
          <lpage>3969</lpage>
          <pub-id pub-id-type="pmid">20573424</pub-id>
        </citation>
      </ref>
      <ref id="B6-molbank-2011-M733">
        <label>6.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gibson</surname>
              <given-names>N.W.</given-names>
            </name>
            <name>
              <surname>Erickson</surname>
              <given-names>L.C.</given-names>
            </name>
            <name>
              <surname>Hickman</surname>
              <given-names>J.A.</given-names>
            </name>
          </person-group>
          <article-title>Effects of the antitumor agent 8-carbamoyl-3-(2-chloroethyl) imidazo [5, 1-<italic>d</italic>]-1, 2, 3, 5-tetrazin-4(3<italic>H</italic>)-one on the DNA of mouse L1210 cells</article-title>
          <source>Cancer Res.</source>
          <year>1984</year>
          <volume>44</volume>
          <fpage>1767</fpage>
          <lpage>1771</lpage>
          <pub-id pub-id-type="pmid">6713380</pub-id>
        </citation>
      </ref>
      <ref id="B7-molbank-2011-M733">
        <label>7.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Smith</surname>
              <given-names>R.H.</given-names>
            </name>
            <name>
              <surname>Scudiero</surname>
              <given-names>D.A.</given-names>
            </name>
            <name>
              <surname>Michejda</surname>
              <given-names>C.J.</given-names>
            </name>
          </person-group>
          <article-title>1, 3-Dialkyl-3-acyltriazenes, a novel class of antineoplastic alkylating agents</article-title>
          <source>J. Med. Chem.</source>
          <year>1990</year>
          <volume>33</volume>
          <fpage>2579</fpage>
          <lpage>2583</lpage>
          <pub-id pub-id-type="doi">10.1021/jm00171a036</pub-id>
          <pub-id pub-id-type="pmid">2391696</pub-id>
        </citation>
      </ref>
      <ref id="B8-molbank-2011-M733">
        <label>8.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sztanke</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Rzymowska</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Niemczyk</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Dyba&#x142;a</surname>
              <given-names>I.</given-names>
            </name>
            <name>
              <surname>Kozio&#x142;</surname>
              <given-names>A.E.</given-names>
            </name>
          </person-group>
          <article-title>Synthesis, crystal structure and anticancer activity of novel derivatives of ethyl 1-(4-oxo-8-aryl-4,6,7,8 tetrahydroimidazo[2,1-<italic>c</italic>][1,2,4]triazin-3-yl)formate</article-title>
          <source>Eur. J. Med. Chem.</source>
          <year>2006</year>
          <volume>41</volume>
          <fpage>539</fpage>
          <lpage>547</lpage>
          <pub-id pub-id-type="doi">10.1016/j.ejmech.2006.01.016</pub-id>
          <pub-id pub-id-type="pmid">16545495</pub-id>
        </citation>
      </ref>
      <ref id="B9-molbank-2011-M733">
        <label>9.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sztanke</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Pasternak</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Sztanke</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Kandefer-Szerszen</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Kozio&#x142;</surname>
              <given-names>A.E.</given-names>
            </name>
            <name>
              <surname>Dyba&#x142;a</surname>
              <given-names>I.</given-names>
            </name>
          </person-group>
          <article-title>Crystal structure, antitumour and antimetastatic activities of disubstituted fused 1,2,4-triazinones</article-title>
          <source>Bioorg. Med. Chem. Lett.</source>
          <year>2009</year>
          <volume>19</volume>
          <fpage>5095</fpage>
          <lpage>5100</lpage>
          <pub-id pub-id-type="doi">10.1016/j.bmcl.2009.07.036</pub-id>
          <pub-id pub-id-type="pmid">19631534</pub-id>
        </citation>
      </ref>
      <ref id="B10-molbank-2011-M733">
        <label>10.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Singh</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Husain</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Athar</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Azam</surname>
              <given-names>A.</given-names>
            </name>
          </person-group>
          <article-title>Synthesis and antiamoebic activity of 3, 7- dimethyl-pyrazolo [3, 4-<italic>e</italic>][1,2,4] triazin-4-yl thiosemicarbazide derivatives</article-title>
          <source>Eur. J. Pharma. Sci.</source>
          <year>2005</year>
          <volume>25</volume>
          <fpage>255</fpage>
          <lpage>262</lpage>
          <pub-id pub-id-type="doi">10.1016/j.ejps.2005.02.014</pub-id>
          <pub-id pub-id-type="pmid">15911221</pub-id>
        </citation>
      </ref>
      <ref id="B11-molbank-2011-M733">
        <label>11.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Abdel-Rahman</surname>
              <given-names>R.M.</given-names>
            </name>
            <name>
              <surname>Saeda</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Fawzy</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>El-Baz</surname>
              <given-names>M.</given-names>
            </name>
          </person-group>
          <article-title>Synthesis of some new 1, 6-dihydro-3-substituted 6-spiro-(9'-fluorene)-1, 2, 4-triazin-5-(4<italic>H</italic>)-ones as potential anti HIV and anticancer drugs</article-title>
          <source>Pharmazie</source>
          <year>1994</year>
          <volume>49</volume>
          <fpage>729</fpage>
          <lpage>733</lpage>
          <pub-id pub-id-type="doi">10.1002/chin.199512225</pub-id>
          <pub-id pub-id-type="pmid">7816899</pub-id>
        </citation>
      </ref>
      <ref id="B12-molbank-2011-M733">
        <label>12.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Katiyar</surname>
              <given-names>S.B.</given-names>
            </name>
            <name>
              <surname>Srivastava</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Puri</surname>
              <given-names>S.K.</given-names>
            </name>
            <name>
              <surname>Chauhan</surname>
              <given-names>P.M.S.</given-names>
            </name>
          </person-group>
          <article-title>Synthesis of 2-[3, 5- Substituted Pyrazol-1-yl]-4, 6-trisubstituted triazine derivatives as antimalarial agents</article-title>
          <source>Bioorg. Med. Chem. Lett.</source>
          <year>2005</year>
          <volume>15</volume>
          <fpage>4957</fpage>
          <lpage>4960</lpage>
          <pub-id pub-id-type="doi">10.1016/j.bmcl.2005.08.023</pub-id>
          <pub-id pub-id-type="pmid">16168643</pub-id>
        </citation>
      </ref>
      <ref id="B13-molbank-2011-M733">
        <label>13.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Srinivas</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Srinivas</surname>
              <given-names>U.</given-names>
            </name>
            <name>
              <surname>Jayathirtha</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Bhanuprakash</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Harakishore</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Murthy</surname>
              <given-names>U.S.N.</given-names>
            </name>
          </person-group>
          <article-title>Synthesis and antibacterial activity of 2,4,6-trisubstituted <italic>s</italic>-triazines</article-title>
          <source>Bioorg. Med. Chem. Lett.</source>
          <year>2005</year>
          <volume>15</volume>
          <fpage>1121</fpage>
          <lpage>1123</lpage>
          <pub-id pub-id-type="doi">10.1016/j.bmcl.2004.12.020</pub-id>
          <pub-id pub-id-type="pmid">15686925</pub-id>
        </citation>
      </ref>
      <ref id="B14-molbank-2011-M733">
        <label>14.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Deshmukh</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Jha</surname>
              <given-names>A.K.</given-names>
            </name>
            <name>
              <surname>Thakur</surname>
              <given-names>A.S.</given-names>
            </name>
            <name>
              <surname>Dewangan</surname>
              <given-names>D.</given-names>
            </name>
          </person-group>
          <article-title>Synthesis and antibacterial activity of some 1, 3, 4-oxadiazole derivatives and their thione analogues</article-title>
          <source>Int. J. Res. Pharma. Bio. Sci.</source>
          <year>2011</year>
          <volume>2</volume>
          <fpage>215</fpage>
          <lpage>219</lpage>
        </citation>
      </ref>
      <ref id="B15-molbank-2011-M733">
        <label>15.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Saravanan</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Mohan</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Roy</surname>
              <given-names>J.J.</given-names>
            </name>
          </person-group>
          <article-title>Synthesis of some 3-substituted amino-4,5-tetramethylene thieno[2,3-<italic>d</italic>][ 1,2,3]-triazin-4(3<italic>H</italic>)-ones as potential antimicrobial agents</article-title>
          <source>Eur. J. Med. Chem.</source>
          <year>2010</year>
          <volume>45</volume>
          <fpage>4365</fpage>
          <lpage>4369</lpage>
          <pub-id pub-id-type="doi">10.1016/j.ejmech.2010.05.061</pub-id>
          <pub-id pub-id-type="pmid">20579782</pub-id>
        </citation>
      </ref>
      <ref id="B16-molbank-2011-M733">
        <label>16.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sangshetti</surname>
              <given-names>J.N.</given-names>
            </name>
            <name>
              <surname>Shinde</surname>
              <given-names>D.B.</given-names>
            </name>
          </person-group>
          <article-title>One pot synthesis and SAR of some novel 3-substituted 5,6-diphenyl-1,2,4-triazines as antifungal agents</article-title>
          <source>Bioorg. Med. Chem. Lett.</source>
          <year>2010</year>
          <volume>20</volume>
          <fpage>742</fpage>
          <lpage>745</lpage>
          <pub-id pub-id-type="doi">10.1016/j.bmcl.2009.11.048</pub-id>
          <pub-id pub-id-type="pmid">20005098</pub-id>
        </citation>
      </ref>
      <ref id="B17-molbank-2011-M733">
        <label>17.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hunt</surname>
              <given-names>J.C.A.</given-names>
            </name>
            <name>
              <surname>Briggs</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Clarke</surname>
              <given-names>E.D.</given-names>
            </name>
            <name>
              <surname>Whittingham</surname>
              <given-names>W.G.</given-names>
            </name>
          </person-group>
          <article-title>Synthesis and SAR studies of novel antifungal 1,2,3-triazines</article-title>
          <source>Bioorg. Med. Chem. Lett.</source>
          <year>2007</year>
          <volume>17</volume>
          <fpage>5222</fpage>
          <lpage>5226</lpage>
          <pub-id pub-id-type="doi">10.1016/j.bmcl.2007.06.076</pub-id>
          <pub-id pub-id-type="pmid">17656087</pub-id>
        </citation>
      </ref>
      <ref id="B18-molbank-2011-M733">
        <label>18.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Dawane</surname>
              <given-names>B.S.</given-names>
            </name>
            <name>
              <surname>Kadam</surname>
              <given-names>S.N.</given-names>
            </name>
            <name>
              <surname>Shaikh</surname>
              <given-names>B.M.</given-names>
            </name>
          </person-group>
          <article-title>An efficient synthesis of 1, 2, 4-triazine derivatives and their <italic>in vitro</italic> antimicrobial activity</article-title>
          <source>Der. Pharmacia Lett.</source>
          <year>2010</year>
          <volume>2</volume>
          <fpage>126</fpage>
          <lpage>131</lpage>
        </citation>
      </ref>
      <ref id="B19-molbank-2011-M733">
        <label>19.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yang</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Kaplan</surname>
              <given-names>P.A.</given-names>
            </name>
          </person-group>
          <article-title>Reaction of isothiourea with 2,3-diaza-3-pentenedioic anhydride: A solid-phase synthesis of 3-amino-1,2,4-triazin-5(4<italic>H</italic>)-ones</article-title>
          <source>Tetrahedron Lett.</source>
          <year>2001</year>
          <volume>42</volume>
          <fpage>4433</fpage>
          <lpage>4435</lpage>
          <pub-id pub-id-type="doi">10.1016/S0040-4039(01)00766-3</pub-id>
        </citation>
      </ref>
      <ref id="B20-molbank-2011-M733">
        <label>20.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Oettmeier</surname>
              <given-names>W.</given-names>
            </name>
            <name>
              <surname>Hilp</surname>
              <given-names>U.</given-names>
            </name>
            <name>
              <surname>Draber</surname>
              <given-names>W.</given-names>
            </name>
          </person-group>
          <article-title>Structure-activity relationships of triazinone herbicides on resistant weeds and resistant chlamydomonas reinhardtii</article-title>
          <source>Pestic. Soc.</source>
          <year>1991</year>
          <volume>33</volume>
          <fpage>399</fpage>
          <lpage>409</lpage>
          <pub-id pub-id-type="doi">10.1002/ps.2780330402</pub-id>
        </citation>
      </ref>
      <ref id="B21-molbank-2011-M733">
        <label>21.</label>
        <citation citation-type="patent">
          <person-group person-group-type="author">
            <name>
              <surname>Kranz</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Santel</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Luerssen</surname>
              <given-names>K.</given-names>
            </name>
          </person-group>
          <article-title>New 6-cyclo-butyl-1, 2, 4-triazinone derivatives&#x2014;useful as herbicides and plant growth regulators</article-title>
          <patent>DE: 3917043 A1</patent>
          <year>1990</year>
        </citation>
      </ref>
      <ref id="B22-molbank-2011-M733">
        <label>22.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kaushik</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Verma</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Madaan</surname>
              <given-names>K.</given-names>
            </name>
          </person-group>
          <article-title>2-(Benzoylamino)-3-(5-chloro-3-methyl-1-phenyl-1<italic>H</italic>-pyrazol-4-yl)acrylic acid</article-title>
          <source>Molbank</source>
          <year>2011</year>
          <volume>2011</volume>
          <fpage>M726</fpage>
          <pub-id pub-id-type="doi">10.3390/M726</pub-id>
        </citation>
      </ref>
    </ref-list>
    <sec sec-type="display-objects">
      <title>Scheme</title>
      <fig id="molbank-2011-M733-sch001" position="float">
        <object-id pub-id-type="pii">molbank-2011-M733-sch001_Scheme 1</object-id>
        <label>Scheme 1</label>
        <caption>
          <p>Synthetic route to the title compound.</p>
        </caption>
        <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="molbank-2011-M733-sch001.tif"/>
      </fig>
    </sec>
  </back>
</article>
